Continued improvement and normalization of myocardial T2* in patients with β- thalassemia major treated with deferasirox (Exjade®) for up to 3 years / D. Pennell, J.B. Porter, M.D. Cappellini, L.L. Chan, A. El Beshlawy, Y. Aydinok, H. Ibrahim, C.K. Li, V. Viprakasit, M.S. Elalfy, A. Kattamis, G. Smith, D. Habr, G. Domokos, B. Roubert, A. Taher. - In: BLOOD. - ISSN 0006-4971. - 116:21(2010 Nov), pp. 1735-1736. ((Intervento presentato al 52. convegno ASH Annual Meeting tenutosi a Orlando, Florida nel 2010.
Continued improvement and normalization of myocardial T2* in patients with β- thalassemia major treated with deferasirox (Exjade®) for up to 3 years
M.D. Cappellini;
2010
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
